KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Current Assets (2017 - 2025)

Historic Current Assets for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $48.8 million.

  • Bionano Genomics' Current Assets rose 387.4% to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year increase of 387.4%. This contributed to the annual value of $39.5 million for FY2024, which is 7181.73% down from last year.
  • Latest data reveals that Bionano Genomics reported Current Assets of $48.8 million as of Q3 2025, which was up 387.4% from $42.7 million recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Current Assets peaked at $370.3 million during Q1 2021, and registered a low of $39.5 million during Q4 2024.
  • Its 5-year average for Current Assets is $160.0 million, with a median of $140.1 million in 2023.
  • As far as peak fluctuations go, Bionano Genomics' Current Assets soared by 208025.56% in 2021, and later crashed by 7181.73% in 2024.
  • Over the past 5 years, Bionano Genomics' Current Assets (Quarter) stood at $272.4 million in 2021, then plummeted by 42.26% to $157.3 million in 2022, then dropped by 10.92% to $140.1 million in 2023, then plummeted by 71.82% to $39.5 million in 2024, then rose by 23.58% to $48.8 million in 2025.
  • Its Current Assets was $48.8 million in Q3 2025, compared to $42.7 million in Q2 2025 and $44.9 million in Q1 2025.